IVD

Blood Test Gives Greater Insight on Heart Attack Risk After Surgery

A new study conducted by researchers from Hamilton Health Sciences shows a blood test done before surgery can predict who will experience adverse cardiovascular outcomes after most types of procedures.

FTC Brings Illumina and PacBio Merger to a Screeching Halt

The Federal Trade Commission said it is challenging the $1.2 billion-merger between Illumina and PacificBio because it could create a monopoly in the U.S. market for next-generation DNA sequencing.

FoundationOne CDx by Foundation Medicine Inc.

Foundation Medicine Expands Companion Diagnostics Offerings

Identifying specific mutations can help match patients to targeted therapies.

C2N Diagnostics Brings Home Positive Results for Alzheimer’s Test

The St. Louis-based company unveiled the results at the 12th Annual Clinical Trials in Alzheimer’s Disease conference.

PGDx Cancer Assay Wins IDE to Be Used in Merck Trial

The Baltimore-based company’s elio assay will be used to analyze genomic markets to direct patient enrollment and stratification.

Say What … Using AI to Discover Signs of Heart Disease on Lung Cancer Screens?

The research on the artificial intelligence solution was presented at the annual meeting of the Radiological Society of North America.

Tiny Circuits Made of DNA Used for Cancer Detection

The detection tool was developed by Duke University Researchers and could help ensure that cancer screens and therapies zero in on the right culprits.

Supporting the Digital Movement of Diagnostics Data

Beckman Coulter employs informatics to automate sample processing and the delivery of testing results.

Thermo Fisher Rumored to Be Interested in Acquiring Qiagen

Waltham, MA-based Thermo Fisher Scientific could be acquiring Qiagen, according to a report from Bloomberg citing people with knowledge of the matter.

Guardant Eyes Approval for Lunar Through ECLIPSE

The liquid biopsy pioneer is developing the Lunar-2 test, which is being evaluated for early colorectal cancer screening.

The Journey of Developing a Novel Point-Of-Care Diagnostic

Kfir Oved co-founder and CTO of MeMed is set to describe the decade-long journey of trying to tackle the global healthcare challenge of antibiotics misuse and the rise of antimicrobial resistance at the BioMed Device San Jose next month.

Could Testing for RNA in Addition to DNA Make a Difference in Cancer?

Ambry Genetics’s +RNAinsight performs both DNA and RNA genetic testing at the same time, which according to a pilot study increases identification of disease-causing DNA mutations.

FDA Gives Nod for Breakthrough HIV Test

FDA authorized the marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next-generation sequencing technology.

Diagnosing Sepsis in Minutes

Cytovale has just received new funding through HHS’s Biomedical Advanced Research and Development Authority (BARDA) to advance its rapid diagnostics platform employing microfluidics, high-speed imaging, and machine learning.

Blood Test Can Detect Breast Cancer 5 Years Before Symptoms Occur

Researchers at the University of Nottingham presented findings about the test at the 2019 NCRI Cancer Conference.

Grail Stays at Forefront of Liquid Biopsy Conversation with New Results

The Menlo Park, CA-based company announced data validating the performance of its investigational multi-cancer early detection blood test for the first time in an independent cohort of participants.

Qmed Search Form